Who would have thought that microbiome targeted therapies would have become such a major focus in drug development? With multiple microbiome-based candidates in early-phase pre-clinical and clinical development, there is a growing demand for manufacturing capacity suitable for the production of live biotherapeutic products (LBP’s). The importance of appropriately designed facilities to ensure effective conditions for scale-up and manufacture of these LPBs cannot be underestimated as part of an overall market access strategy.
DPS has been privileged to work with companies developing these live biotherapeutic products and can support your teams with their manufacturing facility feasibility planning and execution, call us today.
This project was a fit-out of approximately 85,000 sf of cGMP pilot plant, laboratory, and office space at 200 Sidney Street in Cambridge, Massachusetts.
DPS Group is a global consulting, engineering and construction management company, serving high-tech industries around the world.
We have industry experts in key locations in Europe, the U.S., Asia and the Middle East, bringing world-class resources and the latest innovative technologies to every project. Connect with a DPS expert in your area today.